InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Kumar Neil, Chief Executive Officer. Officer active across 1 companies, notably BridgeBio Pharma, Inc.. Cumulatively, 9 reports have been recorded. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
68,705 shares
Common Stock
SEC:0000899243-22-018594:0·
7,524 shares
Common Stock
SEC:0000899243-22-007031:0·
7,524 shares
Common Stock
SEC:0000899243-22-007031·
7,523 shares
Common Stock
SEC:0000899243-21-045260·
7,523 shares
Common Stock
SEC:0000899243-21-045260:0·
7,523 shares
Common Stock
SEC:0000899243-21-033438·
7,523 shares
Common Stock
SEC:0000899243-21-033438:0·
7,524 shares
Common Stock
SEC:0000899243-21-019799·
7,524 shares
Common Stock
SEC:0000899243-21-019799:0·
9 of 9 declarations
About Kumar Neil
Neil Kumar is CEO and President of BridgeBio Pharma, Inc. In this role, he is responsible for the strategic and operational leadership of the company. Neil plays a key role in defining growth objectives and optimizing performance. His leadership is essential for ensuring the long-term success of BridgeBio.
